We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.5M
2
INDA icon
iShares MSCI India ETF
INDA
+$9.67M
3
IBKC
IBERIABANK Corp
IBKC
+$8.93M
4
HYT icon
BlackRock Corporate High Yield Fund
HYT
+$8.03M
5
AMZN icon
Amazon
AMZN
+$7.15M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.7M
2
NFLX icon
Netflix
NFLX
+$15.8M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$15.7M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$15.1M
5
MDCO
Medicines Co
MDCO
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFI icon
1351
UNIFI
UFI
$129M
$1K ﹤0.01%
100
-200
-67% -$4.1K
LGTY
1352
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1K ﹤0.01%
100
-700
-88% -$10.4K
HEXO
1353
CALL
DELISTED
HEXO Corp. Common Shares
HEXO
$1K ﹤0.01%
14
+5
+56% +$337
ASAP
1354
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$1K ﹤0.01%
+25
New +$282
CLVS
1355
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
100
– –
NBEV
1356
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1K ﹤0.01%
+700
New +$1.26K
SWI
1357
DELISTED
SolarWinds Corporation Common Stock
SWI
$1K ﹤0.01%
+65
New +$1.2K
QEP
1358
DELISTED
QEP RESOURCES, INC.
QEP
$1K ﹤0.01%
2,229
-19,305
-90% -$46.5K
I
1359
CALL
DELISTED
INTELSAT S. A.
I
$1K ﹤0.01%
500
-44,000
-99% -$184K
VG
1360
DELISTED
Vonage Holdings Corporation
VG
$1K ﹤0.01%
77
-42,743
-100% -$348K
A icon
1361
Agilent Technologies
A
$42.2B
– –
-1,230
Closed -$105K
AAL icon
1362
American Airlines Group
AAL
$10.1B
– –
-12,824
Closed -$292K
AAT
1363
American Assets Trust
AAT
$1.37B
– –
-7,132
Closed -$327K
ABBV icon
1364
PUT
AbbVie
ABBV
$442B
– –
-33,300
Closed -$2.95M
ABR icon
1365
Arbor Realty Trust
ABR
$998M
– –
-6,900
Closed -$99K
ACAD icon
1366
Acadia Pharmaceuticals
ACAD
$5.07B
– –
-884
Closed -$38K
ACM icon
1367
CALL
Aecom
ACM
$8.62B
– –
-35,900
Closed -$1.55M
ACN icon
1368
PUT
Accenture
ACN
$110B
– –
-3,700
Closed -$779K
ACNT icon
1369
Ascent Industries
ACNT
$138M
– –
-2,616
Closed -$34K
ADBE icon
1370
PUT
Adobe
ADBE
$105B
– –
-25,200
Closed -$8.31M
ADI icon
1371
PUT
Analog Devices
ADI
$188B
– –
-50,000
Closed -$5.94M
ADSK icon
1372
PUT
Autodesk
ADSK
$53.1B
– –
-2,100
Closed -$385K
AEE icon
1373
Ameren
AEE
$29.8B
– –
-2,851
Closed -$219K
AEP icon
1374
CALL
American Electric Power
AEP
$67.3B
– –
-50,000
Closed -$4.73M
AER icon
1375
AerCap
AER
$23.5B
– –
-2,656
Closed -$163K
53 54
55
56 57

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.